InsiderTrades

Form 4 for AAPL Apple Inc.

Accepted 2025-04-17 18:31:13 ET · period of report 2025-04-15 · accession 0000320193-25-000048 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-04-17 18:31 2025-04-15 AAPL KONDO CHRIS Principal Accounting Off M - OptEx — +7,373 22.9K +47% —
D 2025-04-17 18:31 2025-04-15 AAPL KONDO CHRIS Principal Accounting Off F - Tax $202.14 -2,887 20.0K -13% -$583.6K
DM 2025-04-17 18:31 2025-04-15 AAPL KONDO CHRIS Principal Accounting Off M - OptEx — -7,373 10.4K -42% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-04-15 M A 7,373 — 22,906 D — — (F1) Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. (F2) The number of securities reported reflects the acquisition on January 31, 2025 of 114 shares of Apple Inc.'s common stock pursuant to the Apple Inc. Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of August 1, 2024 through January 31, 2025.
2 Common Common Stock 2025-04-15 F D 2,887 $202.14 20,019 D — — (F3) Shares withheld by Apple to satisfy tax withholding requirements on vesting of restricted stock units. No shares were sold.
3 Derivative Restricted Stock Unit 2025-04-15 M D 1,914 — 1,914 D — · — to — 1,914 Common Stock (F1) Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. (F1) Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. (F4) This award was granted on September 26, 2021. 12.5% of the award vested on April 15, 2022 and the remaining restricted stock units vest 12.5% in semi-annual installments over the four-year period ending October 15, 2025, subject to the terms and conditions of the underlying award agreement. (F4) This award was granted on September 26, 2021. 12.5% of the award vested on April 15, 2022 and the remaining restricted stock units vest 12.5% in semi-annual installments over the four-year period ending October 15, 2025, subject to the terms and conditions of the underlying award agreement.
4 Derivative Restricted Stock Unit 2025-04-15 M D 2,078 — 6,232 D — · — to — 2,078 Common Stock (F1) Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. (F1) Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. (F5) This award was granted on September 25, 2022. 12.5% of the award vested on April 15, 2023 and the remaining restricted stock units vest 12.5% in semi-annual installments over the four-year period ending October 15, 2026, subject to the terms and conditions of the underlying award agreement (F5) This award was granted on September 25, 2022. 12.5% of the award vested on April 15, 2023 and the remaining restricted stock units vest 12.5% in semi-annual installments over the four-year period ending October 15, 2026, subject to the terms and conditions of the underlying award agreement
5 Derivative Restricted Stock Unit 2025-04-15 M D 1,899 — 9,491 D — · — to — 1,899 Common Stock (F1) Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. (F1) Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. (F6) This award was granted on October 1, 2023. 12.5% of the award vested on April 15, 2024 and the remaining restricted stock units vest 12.5% in semi-annual installments over the four-year period ending October 15, 2027, subject to the terms and conditions of the underlying award agreement. (F6) This award was granted on October 1, 2023. 12.5% of the award vested on April 15, 2024 and the remaining restricted stock units vest 12.5% in semi-annual installments over the four-year period ending October 15, 2027, subject to the terms and conditions of the underlying award agreement.
6 Derivative Restricted Stock Unit 2025-04-15 M D 1,482 — 10,372 D — · — to — 1,482 Common Stock (F1) Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. (F1) Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. (F7) This award was granted on September 29, 2024. 12.5% of the award vested on April 15, 2025 and the remaining restricted stock units vest 12.5% in semi-annual installments over the four-year period ending October 15, 2028, subject to the terms and conditions of the underlying award agreement. (F7) This award was granted on September 29, 2024. 12.5% of the award vested on April 15, 2025 and the remaining restricted stock units vest 12.5% in semi-annual installments over the four-year period ending October 15, 2028, subject to the terms and conditions of the underlying award agreement.